Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Alastair Greystoke

Newcastle AuthorsTitleYearFull text
Jan Lecouturier
Dr Lisa Crowe
Dr Morven Brown
Professor Alastair Greystoke
Professor Linda Sharp
et al.		“The idea of being without it is frightening”. Uncertainty and psychological dependency for patients using immuno-, biological, or precision therapies: a qualitative study2025
Dr Pawan Gulati
Dr Vickyanne Carruthers
Dr Claire Hutton
Chloe Cassidy
Dr Edward Amankwatia
et al.		An assessment of circulating biomarkers and germline genetic variants in predicting chemotherapy associated mucositis in Ewing sarcoma2025
Iakov Bolnykh
Professor Hamish McAllister-Williams
Professor Alastair Greystoke
Professor Adam Todd
Professor Linda Sharp
Breast cancer patients with a pre-existing mental illness are less likely to receive guideline-recommended cancer treatment: a systematic review and meta-analysis2025
Dr Lisa Crowe
Dr Morven Brown
Jan Lecouturier
Professor Alastair Greystoke
Dr Desy Nuryunarsih
et al.		Development of the SCNS-TARGET: a new tool to assess unmet needs in cancer patients utilising immuno-, biological or precision therapies2025
Professor Alastair Greystoke
Professor Deborah Tweddle
Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology2025
Professor Alastair Greystoke
Hydroxychloroquine in combination with platinum doublet chemotherapy as first-line treatment for extensive-stage small cell lung cancer (Study 15): A randomised phase II multicentre trial2025
Professor Alastair Greystoke
Molecular Tumor Boards: A Consensus Statement From the International Association for the Study of Lung Cancer2025
Professor Alastair Greystoke
Pembrolizumab With or Without Maintenance Olaparib for Metastatic Squamous NSCLC That Responded to First-Line Pembrolizumab Plus Chemotherapy2025
Ruth Norris
Dr Liz Fuller
Professor Alastair Greystoke
Professor Adam Todd
Professor Linda Sharp
Routes to Diagnosis in Lung Cancer—Do Socio-Demographics Matter? An English Population-Based Study2025
Professor Alastair Greystoke
Targeted therapy for older patients with an oncogene driven non-small cell lung cancer: Recommendations from a SIOG expert group2025
Jenny Welford
Professor Alastair Greystoke
The care of older patients with cancer across the United Kingdom in 2024: A narrative review by the International Society of Geriatric Oncology UK Country Group2025
Dr Lisa Crowe
Dr Morven Brown
Dr Jan Lecouturier
Professor Alastair Greystoke
Professor Linda Sharp
et al.		“Oh when’s your treatment ending?” “Never!” The unmet needs of cancer patients treated with immuno-, biological and precision therapies: a qualitative interview study2024
Professor Alastair Greystoke
A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors2024
Professor Alastair Greystoke
Professor Ruth Plummer
Dr Christoph Oing
Dr Pasquale Rescigno
Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis2024
Professor Alastair Greystoke
First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study2024
12345